Locate Bio: Raises £2.25M in Funding
- Locate Bio, a Nottingham, UK-based biotech company which is developing new treatments for patients with serious spinal conditions, closed £2.25m funding round
- The round, which brings the total raised by the company to over £8m, was led by Mercia Asset Management
- Then the company intends to use the funds to continue its research and bring its first products to market
- Locate Bio is advancing products that also improve the lives of people with debilitating spinal conditions
- Locate Bio is a spin-out from the University of Nottingham and based on the research of Professor Kevin Shakesheff, a world-leading expert in regenerative medicine
- The company, which also initially started out as a contract research organisation, first received investment from Mercia in 2018
